Global Exosomes Market Growth (Status and Outlook) 2026-2032
The global Exosomes market size is predicted to grow from US$ 718 million in 2025 to US$ 1982 million in 2032; it is expected to grow at a CAGR of 15.9% from 2026 to 2032.
Exosomes are nanoscale extracellular vesicles with diameters of approximately 30?150 nanometers, secreted by various cell types through exocytosis under physiological or pathological conditions. Found in biological fluids such as blood, urine, and cerebrospinal fluid, they carry a wide range of biomolecules including proteins, lipids, DNA, mRNA, and miRNA, playing a key role in intercellular communication, immune regulation, tumor progression, tissue repair, and neurodegenerative disease pathways. Advances in nanoscale isolation technologies, biomarker identification, and high-throughput omics research have positioned exosomes as powerful tools for liquid biopsy and early disease diagnosis, as well as promising vectors for targeted drug delivery, immune modulation therapies, and regenerative medicine. Today, exosomes are transitioning from research applications to commercial clinical products and novel drug development, serving as a critical component of precision medicine, cell therapy, and RNA-based therapeutics, attracting significant attention from regulatory agencies and global investors.
The exosome industry is experiencing rapid expansion, driven by surging demand for precision medicine, breakthroughs in liquid biopsy and early diagnostic technologies, and the commercialization of RNA drug delivery platforms. According to reports from leading pharmaceutical and biotech companies, exosomes have been incorporated into oncology, immunology, and neurodegenerative disease pipelines, with several candidates advancing into clinical trials. Capital investment remains strong, and leading CDMO providers are accelerating the development of exosome manufacturing processes and GMP-compliant facilities. Government support for regenerative medicine and advanced therapies is further accelerating the transition of exosomes from research to commercial-scale production. With their natural delivery capabilities and low immunogenicity, exosomes are emerging as a key complement to cell and nucleic acid therapeutics, offering vast market potential.
Despite its high growth potential, the exosome sector faces substantial challenges, including high technical barriers, lack of standardized protocols, and an evolving commercial model. Current isolation and purification techniques remain costly and low-yield, hindering scalability. Global regulatory frameworks are fragmented, with significant variations in quality control, clinical certification, and safety evaluation requirements, slowing commercialization and global market expansion. Additionally, intense competition in intellectual property creates significant entry barriers, particularly for smaller firms. Investor caution over clinical progress and commercialization strategies also introduces uncertainty, emphasizing the need for continuous technological innovation and scalable manufacturing solutions.
Downstream applications are rapidly expanding from research-driven markets to commercial clinical services and therapeutic products. The growth of liquid biopsy is enhancing exosomes? role as a non-invasive diagnostic biomarker, while their use in drug delivery and immune modulation is improving the precision and safety of cell and gene therapies. The aesthetics and anti-aging markets are also creating new demand for exosome-based products. Advances in AI-driven omics, automated purification platforms, and scalable bioprocessing will enable high-throughput, high-sensitivity, and industrial-scale production. With the rapid growth of precision medicine and RNA therapeutics, exosomes are poised to become a major innovation driver in the biopharmaceutical industry over the next 5?10 years.
LPI (LP Information)' newest research report, the ?Exosomes Industry Forecast? looks at past sales and reviews total world Exosomes sales in 2025, providing a comprehensive analysis by region and market sector of projected Exosomes sales for 2026 through 2032. With Exosomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosomes industry.
This Insight Report provides a comprehensive analysis of the global Exosomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Exosomes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosomes.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosomes market by product type, application, key players and key regions and countries.
Segmentation by Type:
Exosomes are nanoscale extracellular vesicles with diameters of approximately 30?150 nanometers, secreted by various cell types through exocytosis under physiological or pathological conditions. Found in biological fluids such as blood, urine, and cerebrospinal fluid, they carry a wide range of biomolecules including proteins, lipids, DNA, mRNA, and miRNA, playing a key role in intercellular communication, immune regulation, tumor progression, tissue repair, and neurodegenerative disease pathways. Advances in nanoscale isolation technologies, biomarker identification, and high-throughput omics research have positioned exosomes as powerful tools for liquid biopsy and early disease diagnosis, as well as promising vectors for targeted drug delivery, immune modulation therapies, and regenerative medicine. Today, exosomes are transitioning from research applications to commercial clinical products and novel drug development, serving as a critical component of precision medicine, cell therapy, and RNA-based therapeutics, attracting significant attention from regulatory agencies and global investors.
The exosome industry is experiencing rapid expansion, driven by surging demand for precision medicine, breakthroughs in liquid biopsy and early diagnostic technologies, and the commercialization of RNA drug delivery platforms. According to reports from leading pharmaceutical and biotech companies, exosomes have been incorporated into oncology, immunology, and neurodegenerative disease pipelines, with several candidates advancing into clinical trials. Capital investment remains strong, and leading CDMO providers are accelerating the development of exosome manufacturing processes and GMP-compliant facilities. Government support for regenerative medicine and advanced therapies is further accelerating the transition of exosomes from research to commercial-scale production. With their natural delivery capabilities and low immunogenicity, exosomes are emerging as a key complement to cell and nucleic acid therapeutics, offering vast market potential.
Despite its high growth potential, the exosome sector faces substantial challenges, including high technical barriers, lack of standardized protocols, and an evolving commercial model. Current isolation and purification techniques remain costly and low-yield, hindering scalability. Global regulatory frameworks are fragmented, with significant variations in quality control, clinical certification, and safety evaluation requirements, slowing commercialization and global market expansion. Additionally, intense competition in intellectual property creates significant entry barriers, particularly for smaller firms. Investor caution over clinical progress and commercialization strategies also introduces uncertainty, emphasizing the need for continuous technological innovation and scalable manufacturing solutions.
Downstream applications are rapidly expanding from research-driven markets to commercial clinical services and therapeutic products. The growth of liquid biopsy is enhancing exosomes? role as a non-invasive diagnostic biomarker, while their use in drug delivery and immune modulation is improving the precision and safety of cell and gene therapies. The aesthetics and anti-aging markets are also creating new demand for exosome-based products. Advances in AI-driven omics, automated purification platforms, and scalable bioprocessing will enable high-throughput, high-sensitivity, and industrial-scale production. With the rapid growth of precision medicine and RNA therapeutics, exosomes are poised to become a major innovation driver in the biopharmaceutical industry over the next 5?10 years.
LPI (LP Information)' newest research report, the ?Exosomes Industry Forecast? looks at past sales and reviews total world Exosomes sales in 2025, providing a comprehensive analysis by region and market sector of projected Exosomes sales for 2026 through 2032. With Exosomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosomes industry.
This Insight Report provides a comprehensive analysis of the global Exosomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Exosomes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosomes.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosomes market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Scientific Research Products
- Beauty and Anti-aging
- Treatment and Diagnosis
- Mammalian Cells
- Stem Cells
- Immune Cells
- Plant Derived
- Research Institutes
- Pharma Biotech
- Hospitals Clinics
- Cosmetic Companies
- Tumors
- Neurological Diseases
- Regenerative Medicine
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CellResearch
- ExoCoBio
- Skinlabs Medical
- Thermo Fisher Scientific
- Qiagen
- System Biosciences (SBI)
- Merck
- Norgen Biotek
- StemCells21
- Codiak Biosciences
- Exosome Diagnostics
- Evox Therapeutics
- Aegle Therapeutics
- Danaher
- Lonza
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exosomes Market Size (2021-2032)
2.1.2 Exosomes Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Exosomes by Country/Region (2021, 2025 & 2032)
2.2 Exosomes Segment by Type
2.2.1 Scientific Research Products
2.2.2 Beauty and Anti-aging
2.2.3 Treatment and Diagnosis
2.2.4 Exosomes Market Size by Type
2.2.4.1 Exosomes Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Exosomes Market Size Market Share by Type (2021-2026)
2.3 Exosomes Segment by Source Type
2.3.1 Mammalian Cells
2.3.2 Stem Cells
2.3.3 Immune Cells
2.3.4 Plant Derived
2.3.5 Exosomes Market Size by Source Type
2.3.5.1 Exosomes Market Size CAGR by Source Type (2021 VS 2025 VS 2032)
2.3.5.2 Global Exosomes Market Size Market Share by Source Type (2021-2026)
2.4 Exosomes Segment by End User
2.4.1 Research Institutes
2.4.2 Pharma Biotech
2.4.3 Hospitals Clinics
2.4.4 Cosmetic Companies
2.4.5 Exosomes Market Size by End User
2.4.5.1 Exosomes Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.4.5.2 Global Exosomes Market Size Market Share by End User (2021-2026)
2.5 Exosomes Segment by Application
2.5.1 Tumors
2.5.2 Neurological Diseases
2.5.3 Regenerative Medicine
2.5.4 Other
2.5.5 Exosomes Market Size by Application
2.5.5.1 Exosomes Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Exosomes Market Size Market Share by Application (2021-2026)
3 EXOSOMES MARKET SIZE BY PLAYER
3.1 Exosomes Market Size Market Share by Player
3.1.1 Global Exosomes Revenue by Player (2021-2026)
3.1.2 Global Exosomes Revenue Market Share by Player (2021-2026)
3.2 Global Exosomes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOSOMES BY REGION
4.1 Exosomes Market Size by Region (2021-2026)
4.2 Global Exosomes Annual Revenue by Country/Region (2021-2026)
4.3 Americas Exosomes Market Size Growth (2021-2026)
4.4 APAC Exosomes Market Size Growth (2021-2026)
4.5 Europe Exosomes Market Size Growth (2021-2026)
4.6 Middle East & Africa Exosomes Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Exosomes Market Size by Country (2021-2026)
5.2 Americas Exosomes Market Size by Type (2021-2026)
5.3 Americas Exosomes Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosomes Market Size by Region (2021-2026)
6.2 APAC Exosomes Market Size by Type (2021-2026)
6.3 APAC Exosomes Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exosomes Market Size by Country (2021-2026)
7.2 Europe Exosomes Market Size by Type (2021-2026)
7.3 Europe Exosomes Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exosomes by Region (2021-2026)
8.2 Middle East & Africa Exosomes Market Size by Type (2021-2026)
8.3 Middle East & Africa Exosomes Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOSOMES MARKET FORECAST
10.1 Global Exosomes Forecast by Region (2027-2032)
10.1.1 Global Exosomes Forecast by Region (2027-2032)
10.1.2 Americas Exosomes Forecast
10.1.3 APAC Exosomes Forecast
10.1.4 Europe Exosomes Forecast
10.1.5 Middle East & Africa Exosomes Forecast
10.2 Americas Exosomes Forecast by Country (2027-2032)
10.2.1 United States Market Exosomes Forecast
10.2.2 Canada Market Exosomes Forecast
10.2.3 Mexico Market Exosomes Forecast
10.2.4 Brazil Market Exosomes Forecast
10.3 APAC Exosomes Forecast by Region (2027-2032)
10.3.1 China Exosomes Market Forecast
10.3.2 Japan Market Exosomes Forecast
10.3.3 Korea Market Exosomes Forecast
10.3.4 Southeast Asia Market Exosomes Forecast
10.3.5 India Market Exosomes Forecast
10.3.6 Australia Market Exosomes Forecast
10.4 Europe Exosomes Forecast by Country (2027-2032)
10.4.1 Germany Market Exosomes Forecast
10.4.2 France Market Exosomes Forecast
10.4.3 UK Market Exosomes Forecast
10.4.4 Italy Market Exosomes Forecast
10.4.5 Russia Market Exosomes Forecast
10.5 Middle East & Africa Exosomes Forecast by Region (2027-2032)
10.5.1 Egypt Market Exosomes Forecast
10.5.2 South Africa Market Exosomes Forecast
10.5.3 Israel Market Exosomes Forecast
10.5.4 Turkey Market Exosomes Forecast
10.6 Global Exosomes Forecast by Type (2027-2032)
10.7 Global Exosomes Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Exosomes Forecast
11 KEY PLAYERS ANALYSIS
11.1 CellResearch
11.1.1 CellResearch Company Information
11.1.2 CellResearch Exosomes Product Offered
11.1.3 CellResearch Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 CellResearch Main Business Overview
11.1.5 CellResearch Latest Developments
11.2 ExoCoBio
11.2.1 ExoCoBio Company Information
11.2.2 ExoCoBio Exosomes Product Offered
11.2.3 ExoCoBio Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 ExoCoBio Main Business Overview
11.2.5 ExoCoBio Latest Developments
11.3 Skinlabs Medical
11.3.1 Skinlabs Medical Company Information
11.3.2 Skinlabs Medical Exosomes Product Offered
11.3.3 Skinlabs Medical Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Skinlabs Medical Main Business Overview
11.3.5 Skinlabs Medical Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Exosomes Product Offered
11.4.3 Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Qiagen
11.5.1 Qiagen Company Information
11.5.2 Qiagen Exosomes Product Offered
11.5.3 Qiagen Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Qiagen Main Business Overview
11.5.5 Qiagen Latest Developments
11.6 System Biosciences (SBI)
11.6.1 System Biosciences (SBI) Company Information
11.6.2 System Biosciences (SBI) Exosomes Product Offered
11.6.3 System Biosciences (SBI) Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 System Biosciences (SBI) Main Business Overview
11.6.5 System Biosciences (SBI) Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Exosomes Product Offered
11.7.3 Merck Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Norgen Biotek
11.8.1 Norgen Biotek Company Information
11.8.2 Norgen Biotek Exosomes Product Offered
11.8.3 Norgen Biotek Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Norgen Biotek Main Business Overview
11.8.5 Norgen Biotek Latest Developments
11.9 StemCells21
11.9.1 StemCells21 Company Information
11.9.2 StemCells21 Exosomes Product Offered
11.9.3 StemCells21 Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 StemCells21 Main Business Overview
11.9.5 StemCells21 Latest Developments
11.10 Codiak Biosciences
11.10.1 Codiak Biosciences Company Information
11.10.2 Codiak Biosciences Exosomes Product Offered
11.10.3 Codiak Biosciences Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Codiak Biosciences Main Business Overview
11.10.5 Codiak Biosciences Latest Developments
11.11 Exosome Diagnostics
11.11.1 Exosome Diagnostics Company Information
11.11.2 Exosome Diagnostics Exosomes Product Offered
11.11.3 Exosome Diagnostics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Exosome Diagnostics Main Business Overview
11.11.5 Exosome Diagnostics Latest Developments
11.12 Evox Therapeutics
11.12.1 Evox Therapeutics Company Information
11.12.2 Evox Therapeutics Exosomes Product Offered
11.12.3 Evox Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Evox Therapeutics Main Business Overview
11.12.5 Evox Therapeutics Latest Developments
11.13 Aegle Therapeutics
11.13.1 Aegle Therapeutics Company Information
11.13.2 Aegle Therapeutics Exosomes Product Offered
11.13.3 Aegle Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aegle Therapeutics Main Business Overview
11.13.5 Aegle Therapeutics Latest Developments
11.14 Danaher
11.14.1 Danaher Company Information
11.14.2 Danaher Exosomes Product Offered
11.14.3 Danaher Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Danaher Main Business Overview
11.14.5 Danaher Latest Developments
11.15 Lonza
11.15.1 Lonza Company Information
11.15.2 Lonza Exosomes Product Offered
11.15.3 Lonza Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Lonza Main Business Overview
11.15.5 Lonza Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exosomes Market Size (2021-2032)
2.1.2 Exosomes Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Exosomes by Country/Region (2021, 2025 & 2032)
2.2 Exosomes Segment by Type
2.2.1 Scientific Research Products
2.2.2 Beauty and Anti-aging
2.2.3 Treatment and Diagnosis
2.2.4 Exosomes Market Size by Type
2.2.4.1 Exosomes Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Exosomes Market Size Market Share by Type (2021-2026)
2.3 Exosomes Segment by Source Type
2.3.1 Mammalian Cells
2.3.2 Stem Cells
2.3.3 Immune Cells
2.3.4 Plant Derived
2.3.5 Exosomes Market Size by Source Type
2.3.5.1 Exosomes Market Size CAGR by Source Type (2021 VS 2025 VS 2032)
2.3.5.2 Global Exosomes Market Size Market Share by Source Type (2021-2026)
2.4 Exosomes Segment by End User
2.4.1 Research Institutes
2.4.2 Pharma Biotech
2.4.3 Hospitals Clinics
2.4.4 Cosmetic Companies
2.4.5 Exosomes Market Size by End User
2.4.5.1 Exosomes Market Size CAGR by End User (2021 VS 2025 VS 2032)
2.4.5.2 Global Exosomes Market Size Market Share by End User (2021-2026)
2.5 Exosomes Segment by Application
2.5.1 Tumors
2.5.2 Neurological Diseases
2.5.3 Regenerative Medicine
2.5.4 Other
2.5.5 Exosomes Market Size by Application
2.5.5.1 Exosomes Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Exosomes Market Size Market Share by Application (2021-2026)
3 EXOSOMES MARKET SIZE BY PLAYER
3.1 Exosomes Market Size Market Share by Player
3.1.1 Global Exosomes Revenue by Player (2021-2026)
3.1.2 Global Exosomes Revenue Market Share by Player (2021-2026)
3.2 Global Exosomes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOSOMES BY REGION
4.1 Exosomes Market Size by Region (2021-2026)
4.2 Global Exosomes Annual Revenue by Country/Region (2021-2026)
4.3 Americas Exosomes Market Size Growth (2021-2026)
4.4 APAC Exosomes Market Size Growth (2021-2026)
4.5 Europe Exosomes Market Size Growth (2021-2026)
4.6 Middle East & Africa Exosomes Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Exosomes Market Size by Country (2021-2026)
5.2 Americas Exosomes Market Size by Type (2021-2026)
5.3 Americas Exosomes Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosomes Market Size by Region (2021-2026)
6.2 APAC Exosomes Market Size by Type (2021-2026)
6.3 APAC Exosomes Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exosomes Market Size by Country (2021-2026)
7.2 Europe Exosomes Market Size by Type (2021-2026)
7.3 Europe Exosomes Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exosomes by Region (2021-2026)
8.2 Middle East & Africa Exosomes Market Size by Type (2021-2026)
8.3 Middle East & Africa Exosomes Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOSOMES MARKET FORECAST
10.1 Global Exosomes Forecast by Region (2027-2032)
10.1.1 Global Exosomes Forecast by Region (2027-2032)
10.1.2 Americas Exosomes Forecast
10.1.3 APAC Exosomes Forecast
10.1.4 Europe Exosomes Forecast
10.1.5 Middle East & Africa Exosomes Forecast
10.2 Americas Exosomes Forecast by Country (2027-2032)
10.2.1 United States Market Exosomes Forecast
10.2.2 Canada Market Exosomes Forecast
10.2.3 Mexico Market Exosomes Forecast
10.2.4 Brazil Market Exosomes Forecast
10.3 APAC Exosomes Forecast by Region (2027-2032)
10.3.1 China Exosomes Market Forecast
10.3.2 Japan Market Exosomes Forecast
10.3.3 Korea Market Exosomes Forecast
10.3.4 Southeast Asia Market Exosomes Forecast
10.3.5 India Market Exosomes Forecast
10.3.6 Australia Market Exosomes Forecast
10.4 Europe Exosomes Forecast by Country (2027-2032)
10.4.1 Germany Market Exosomes Forecast
10.4.2 France Market Exosomes Forecast
10.4.3 UK Market Exosomes Forecast
10.4.4 Italy Market Exosomes Forecast
10.4.5 Russia Market Exosomes Forecast
10.5 Middle East & Africa Exosomes Forecast by Region (2027-2032)
10.5.1 Egypt Market Exosomes Forecast
10.5.2 South Africa Market Exosomes Forecast
10.5.3 Israel Market Exosomes Forecast
10.5.4 Turkey Market Exosomes Forecast
10.6 Global Exosomes Forecast by Type (2027-2032)
10.7 Global Exosomes Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Exosomes Forecast
11 KEY PLAYERS ANALYSIS
11.1 CellResearch
11.1.1 CellResearch Company Information
11.1.2 CellResearch Exosomes Product Offered
11.1.3 CellResearch Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 CellResearch Main Business Overview
11.1.5 CellResearch Latest Developments
11.2 ExoCoBio
11.2.1 ExoCoBio Company Information
11.2.2 ExoCoBio Exosomes Product Offered
11.2.3 ExoCoBio Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 ExoCoBio Main Business Overview
11.2.5 ExoCoBio Latest Developments
11.3 Skinlabs Medical
11.3.1 Skinlabs Medical Company Information
11.3.2 Skinlabs Medical Exosomes Product Offered
11.3.3 Skinlabs Medical Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Skinlabs Medical Main Business Overview
11.3.5 Skinlabs Medical Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Exosomes Product Offered
11.4.3 Thermo Fisher Scientific Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Qiagen
11.5.1 Qiagen Company Information
11.5.2 Qiagen Exosomes Product Offered
11.5.3 Qiagen Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Qiagen Main Business Overview
11.5.5 Qiagen Latest Developments
11.6 System Biosciences (SBI)
11.6.1 System Biosciences (SBI) Company Information
11.6.2 System Biosciences (SBI) Exosomes Product Offered
11.6.3 System Biosciences (SBI) Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 System Biosciences (SBI) Main Business Overview
11.6.5 System Biosciences (SBI) Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Exosomes Product Offered
11.7.3 Merck Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Norgen Biotek
11.8.1 Norgen Biotek Company Information
11.8.2 Norgen Biotek Exosomes Product Offered
11.8.3 Norgen Biotek Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Norgen Biotek Main Business Overview
11.8.5 Norgen Biotek Latest Developments
11.9 StemCells21
11.9.1 StemCells21 Company Information
11.9.2 StemCells21 Exosomes Product Offered
11.9.3 StemCells21 Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 StemCells21 Main Business Overview
11.9.5 StemCells21 Latest Developments
11.10 Codiak Biosciences
11.10.1 Codiak Biosciences Company Information
11.10.2 Codiak Biosciences Exosomes Product Offered
11.10.3 Codiak Biosciences Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Codiak Biosciences Main Business Overview
11.10.5 Codiak Biosciences Latest Developments
11.11 Exosome Diagnostics
11.11.1 Exosome Diagnostics Company Information
11.11.2 Exosome Diagnostics Exosomes Product Offered
11.11.3 Exosome Diagnostics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Exosome Diagnostics Main Business Overview
11.11.5 Exosome Diagnostics Latest Developments
11.12 Evox Therapeutics
11.12.1 Evox Therapeutics Company Information
11.12.2 Evox Therapeutics Exosomes Product Offered
11.12.3 Evox Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Evox Therapeutics Main Business Overview
11.12.5 Evox Therapeutics Latest Developments
11.13 Aegle Therapeutics
11.13.1 Aegle Therapeutics Company Information
11.13.2 Aegle Therapeutics Exosomes Product Offered
11.13.3 Aegle Therapeutics Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Aegle Therapeutics Main Business Overview
11.13.5 Aegle Therapeutics Latest Developments
11.14 Danaher
11.14.1 Danaher Company Information
11.14.2 Danaher Exosomes Product Offered
11.14.3 Danaher Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Danaher Main Business Overview
11.14.5 Danaher Latest Developments
11.15 Lonza
11.15.1 Lonza Company Information
11.15.2 Lonza Exosomes Product Offered
11.15.3 Lonza Exosomes Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Lonza Main Business Overview
11.15.5 Lonza Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Exosomes Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Exosomes Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Scientific Research Products
Table 4. Major Players of Beauty and Anti-aging
Table 5. Major Players of Treatment and Diagnosis
Table 6. Exosomes Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Exosomes Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Mammalian Cells
Table 10. Major Players of Stem Cells
Table 11. Major Players of Immune Cells
Table 12. Major Players of Plant Derived
Table 13. Exosomes Market Size CAGR by Source Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Exosomes Market Size by Source Type (2021-2026) & ($ millions)
Table 15. Global Exosomes Market Size Market Share by Source Type (2021-2026)
Table 16. Major Players of Research Institutes
Table 17. Major Players of Pharma Biotech
Table 18. Major Players of Hospitals Clinics
Table 19. Major Players of Cosmetic Companies
Table 20. Exosomes Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Exosomes Market Size by End User (2021-2026) & ($ millions)
Table 22. Global Exosomes Market Size Market Share by End User (2021-2026)
Table 23. Exosomes Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 25. Global Exosomes Market Size Market Share by Application (2021-2026)
Table 26. Global Exosomes Revenue by Player (2021-2026) & ($ millions)
Table 27. Global Exosomes Revenue Market Share by Player (2021-2026)
Table 28. Exosomes Key Players Head office and Products Offered
Table 29. Exosomes Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Exosomes Market Size by Region (2021-2026) & ($ millions)
Table 33. Global Exosomes Market Size Market Share by Region (2021-2026)
Table 34. Global Exosomes Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Exosomes Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Exosomes Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas Exosomes Market Size Market Share by Country (2021-2026)
Table 38. Americas Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas Exosomes Market Size Market Share by Type (2021-2026)
Table 40. Americas Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas Exosomes Market Size Market Share by Application (2021-2026)
Table 42. APAC Exosomes Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC Exosomes Market Size Market Share by Region (2021-2026)
Table 44. APAC Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe Exosomes Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe Exosomes Market Size Market Share by Country (2021-2026)
Table 48. Europe Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa Exosomes Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of Exosomes
Table 54. Key Market Challenges & Risks of Exosomes
Table 55. Key Industry Trends of Exosomes
Table 56. Global Exosomes Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global Exosomes Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global Exosomes Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global Exosomes Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. CellResearch Details, Company Type, Exosomes Area Served and Its Competitors
Table 61. CellResearch Exosomes Product Offered
Table 62. CellResearch Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. CellResearch Main Business
Table 64. CellResearch Latest Developments
Table 65. ExoCoBio Details, Company Type, Exosomes Area Served and Its Competitors
Table 66. ExoCoBio Exosomes Product Offered
Table 67. ExoCoBio Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. ExoCoBio Main Business
Table 69. ExoCoBio Latest Developments
Table 70. Skinlabs Medical Details, Company Type, Exosomes Area Served and Its Competitors
Table 71. Skinlabs Medical Exosomes Product Offered
Table 72. Skinlabs Medical Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Skinlabs Medical Main Business
Table 74. Skinlabs Medical Latest Developments
Table 75. Thermo Fisher Scientific Details, Company Type, Exosomes Area Served and Its Competitors
Table 76. Thermo Fisher Scientific Exosomes Product Offered
Table 77. Thermo Fisher Scientific Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Thermo Fisher Scientific Main Business
Table 79. Thermo Fisher Scientific Latest Developments
Table 80. Qiagen Details, Company Type, Exosomes Area Served and Its Competitors
Table 81. Qiagen Exosomes Product Offered
Table 82. Qiagen Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Qiagen Main Business
Table 84. Qiagen Latest Developments
Table 85. System Biosciences (SBI) Details, Company Type, Exosomes Area Served and Its Competitors
Table 86. System Biosciences (SBI) Exosomes Product Offered
Table 87. System Biosciences (SBI) Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. System Biosciences (SBI) Main Business
Table 89. System Biosciences (SBI) Latest Developments
Table 90. Merck Details, Company Type, Exosomes Area Served and Its Competitors
Table 91. Merck Exosomes Product Offered
Table 92. Merck Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Norgen Biotek Details, Company Type, Exosomes Area Served and Its Competitors
Table 96. Norgen Biotek Exosomes Product Offered
Table 97. Norgen Biotek Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Norgen Biotek Main Business
Table 99. Norgen Biotek Latest Developments
Table 100. StemCells21 Details, Company Type, Exosomes Area Served and Its Competitors
Table 101. StemCells21 Exosomes Product Offered
Table 102. StemCells21 Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. StemCells21 Main Business
Table 104. StemCells21 Latest Developments
Table 105. Codiak Biosciences Details, Company Type, Exosomes Area Served and Its Competitors
Table 106. Codiak Biosciences Exosomes Product Offered
Table 107. Codiak Biosciences Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Codiak Biosciences Main Business
Table 109. Codiak Biosciences Latest Developments
Table 110. Exosome Diagnostics Details, Company Type, Exosomes Area Served and Its Competitors
Table 111. Exosome Diagnostics Exosomes Product Offered
Table 112. Exosome Diagnostics Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Exosome Diagnostics Main Business
Table 114. Exosome Diagnostics Latest Developments
Table 115. Evox Therapeutics Details, Company Type, Exosomes Area Served and Its Competitors
Table 116. Evox Therapeutics Exosomes Product Offered
Table 117. Evox Therapeutics Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Evox Therapeutics Main Business
Table 119. Evox Therapeutics Latest Developments
Table 120. Aegle Therapeutics Details, Company Type, Exosomes Area Served and Its Competitors
Table 121. Aegle Therapeutics Exosomes Product Offered
Table 122. Aegle Therapeutics Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Aegle Therapeutics Main Business
Table 124. Aegle Therapeutics Latest Developments
Table 125. Danaher Details, Company Type, Exosomes Area Served and Its Competitors
Table 126. Danaher Exosomes Product Offered
Table 127. Danaher Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Danaher Main Business
Table 129. Danaher Latest Developments
Table 130. Lonza Details, Company Type, Exosomes Area Served and Its Competitors
Table 131. Lonza Exosomes Product Offered
Table 132. Lonza Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Lonza Main Business
Table 134. Lonza Latest Developments
Table 1. Exosomes Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Exosomes Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Scientific Research Products
Table 4. Major Players of Beauty and Anti-aging
Table 5. Major Players of Treatment and Diagnosis
Table 6. Exosomes Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Exosomes Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Mammalian Cells
Table 10. Major Players of Stem Cells
Table 11. Major Players of Immune Cells
Table 12. Major Players of Plant Derived
Table 13. Exosomes Market Size CAGR by Source Type (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Exosomes Market Size by Source Type (2021-2026) & ($ millions)
Table 15. Global Exosomes Market Size Market Share by Source Type (2021-2026)
Table 16. Major Players of Research Institutes
Table 17. Major Players of Pharma Biotech
Table 18. Major Players of Hospitals Clinics
Table 19. Major Players of Cosmetic Companies
Table 20. Exosomes Market Size CAGR by End User (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Exosomes Market Size by End User (2021-2026) & ($ millions)
Table 22. Global Exosomes Market Size Market Share by End User (2021-2026)
Table 23. Exosomes Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 25. Global Exosomes Market Size Market Share by Application (2021-2026)
Table 26. Global Exosomes Revenue by Player (2021-2026) & ($ millions)
Table 27. Global Exosomes Revenue Market Share by Player (2021-2026)
Table 28. Exosomes Key Players Head office and Products Offered
Table 29. Exosomes Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Exosomes Market Size by Region (2021-2026) & ($ millions)
Table 33. Global Exosomes Market Size Market Share by Region (2021-2026)
Table 34. Global Exosomes Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Exosomes Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Exosomes Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas Exosomes Market Size Market Share by Country (2021-2026)
Table 38. Americas Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas Exosomes Market Size Market Share by Type (2021-2026)
Table 40. Americas Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas Exosomes Market Size Market Share by Application (2021-2026)
Table 42. APAC Exosomes Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC Exosomes Market Size Market Share by Region (2021-2026)
Table 44. APAC Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe Exosomes Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe Exosomes Market Size Market Share by Country (2021-2026)
Table 48. Europe Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa Exosomes Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa Exosomes Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa Exosomes Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of Exosomes
Table 54. Key Market Challenges & Risks of Exosomes
Table 55. Key Industry Trends of Exosomes
Table 56. Global Exosomes Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global Exosomes Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global Exosomes Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global Exosomes Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. CellResearch Details, Company Type, Exosomes Area Served and Its Competitors
Table 61. CellResearch Exosomes Product Offered
Table 62. CellResearch Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. CellResearch Main Business
Table 64. CellResearch Latest Developments
Table 65. ExoCoBio Details, Company Type, Exosomes Area Served and Its Competitors
Table 66. ExoCoBio Exosomes Product Offered
Table 67. ExoCoBio Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. ExoCoBio Main Business
Table 69. ExoCoBio Latest Developments
Table 70. Skinlabs Medical Details, Company Type, Exosomes Area Served and Its Competitors
Table 71. Skinlabs Medical Exosomes Product Offered
Table 72. Skinlabs Medical Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Skinlabs Medical Main Business
Table 74. Skinlabs Medical Latest Developments
Table 75. Thermo Fisher Scientific Details, Company Type, Exosomes Area Served and Its Competitors
Table 76. Thermo Fisher Scientific Exosomes Product Offered
Table 77. Thermo Fisher Scientific Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Thermo Fisher Scientific Main Business
Table 79. Thermo Fisher Scientific Latest Developments
Table 80. Qiagen Details, Company Type, Exosomes Area Served and Its Competitors
Table 81. Qiagen Exosomes Product Offered
Table 82. Qiagen Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Qiagen Main Business
Table 84. Qiagen Latest Developments
Table 85. System Biosciences (SBI) Details, Company Type, Exosomes Area Served and Its Competitors
Table 86. System Biosciences (SBI) Exosomes Product Offered
Table 87. System Biosciences (SBI) Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. System Biosciences (SBI) Main Business
Table 89. System Biosciences (SBI) Latest Developments
Table 90. Merck Details, Company Type, Exosomes Area Served and Its Competitors
Table 91. Merck Exosomes Product Offered
Table 92. Merck Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Norgen Biotek Details, Company Type, Exosomes Area Served and Its Competitors
Table 96. Norgen Biotek Exosomes Product Offered
Table 97. Norgen Biotek Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Norgen Biotek Main Business
Table 99. Norgen Biotek Latest Developments
Table 100. StemCells21 Details, Company Type, Exosomes Area Served and Its Competitors
Table 101. StemCells21 Exosomes Product Offered
Table 102. StemCells21 Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. StemCells21 Main Business
Table 104. StemCells21 Latest Developments
Table 105. Codiak Biosciences Details, Company Type, Exosomes Area Served and Its Competitors
Table 106. Codiak Biosciences Exosomes Product Offered
Table 107. Codiak Biosciences Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Codiak Biosciences Main Business
Table 109. Codiak Biosciences Latest Developments
Table 110. Exosome Diagnostics Details, Company Type, Exosomes Area Served and Its Competitors
Table 111. Exosome Diagnostics Exosomes Product Offered
Table 112. Exosome Diagnostics Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Exosome Diagnostics Main Business
Table 114. Exosome Diagnostics Latest Developments
Table 115. Evox Therapeutics Details, Company Type, Exosomes Area Served and Its Competitors
Table 116. Evox Therapeutics Exosomes Product Offered
Table 117. Evox Therapeutics Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Evox Therapeutics Main Business
Table 119. Evox Therapeutics Latest Developments
Table 120. Aegle Therapeutics Details, Company Type, Exosomes Area Served and Its Competitors
Table 121. Aegle Therapeutics Exosomes Product Offered
Table 122. Aegle Therapeutics Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Aegle Therapeutics Main Business
Table 124. Aegle Therapeutics Latest Developments
Table 125. Danaher Details, Company Type, Exosomes Area Served and Its Competitors
Table 126. Danaher Exosomes Product Offered
Table 127. Danaher Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Danaher Main Business
Table 129. Danaher Latest Developments
Table 130. Lonza Details, Company Type, Exosomes Area Served and Its Competitors
Table 131. Lonza Exosomes Product Offered
Table 132. Lonza Exosomes Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Lonza Main Business
Table 134. Lonza Latest Developments
LIST OF FIGURES
Figure 1. Exosomes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exosomes Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Exosomes Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Exosomes Sales Market Share by Country/Region (2025)
Figure 8. Exosomes Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Exosomes Market Size Market Share by Type in 2025
Figure 10. Global Exosomes Market Size Market Share by Source Type in 2025
Figure 11. Global Exosomes Market Size Market Share by End User in 2025
Figure 12. Exosomes in Tumors
Figure 13. Global Exosomes Market: Tumors (2021-2026) & ($ millions)
Figure 14. Exosomes in Neurological Diseases
Figure 15. Global Exosomes Market: Neurological Diseases (2021-2026) & ($ millions)
Figure 16. Exosomes in Regenerative Medicine
Figure 17. Global Exosomes Market: Regenerative Medicine (2021-2026) & ($ millions)
Figure 18. Exosomes in Other
Figure 19. Global Exosomes Market: Other (2021-2026) & ($ millions)
Figure 20. Global Exosomes Market Size Market Share by Application in 2025
Figure 21. Global Exosomes Revenue Market Share by Player in 2025
Figure 22. Global Exosomes Market Size Market Share by Region (2021-2026)
Figure 23. Americas Exosomes Market Size 2021-2026 ($ millions)
Figure 24. APAC Exosomes Market Size 2021-2026 ($ millions)
Figure 25. Europe Exosomes Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Exosomes Market Size 2021-2026 ($ millions)
Figure 27. Americas Exosomes Value Market Share by Country in 2025
Figure 28. United States Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Exosomes Market Size Market Share by Region in 2025
Figure 33. APAC Exosomes Market Size Market Share by Type (2021-2026)
Figure 34. APAC Exosomes Market Size Market Share by Application (2021-2026)
Figure 35. China Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 39. India Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Exosomes Market Size Market Share by Country in 2025
Figure 42. Europe Exosomes Market Size Market Share by Type (2021-2026)
Figure 43. Europe Exosomes Market Size Market Share by Application (2021-2026)
Figure 44. Germany Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 45. France Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Exosomes Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Exosomes Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Exosomes Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Exosomes Market Size 2027-2032 ($ millions)
Figure 58. APAC Exosomes Market Size 2027-2032 ($ millions)
Figure 59. Europe Exosomes Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Exosomes Market Size 2027-2032 ($ millions)
Figure 61. United States Exosomes Market Size 2027-2032 ($ millions)
Figure 62. Canada Exosomes Market Size 2027-2032 ($ millions)
Figure 63. Mexico Exosomes Market Size 2027-2032 ($ millions)
Figure 64. Brazil Exosomes Market Size 2027-2032 ($ millions)
Figure 65. China Exosomes Market Size 2027-2032 ($ millions)
Figure 66. Japan Exosomes Market Size 2027-2032 ($ millions)
Figure 67. Korea Exosomes Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Exosomes Market Size 2027-2032 ($ millions)
Figure 69. India Exosomes Market Size 2027-2032 ($ millions)
Figure 70. Australia Exosomes Market Size 2027-2032 ($ millions)
Figure 71. Germany Exosomes Market Size 2027-2032 ($ millions)
Figure 72. France Exosomes Market Size 2027-2032 ($ millions)
Figure 73. UK Exosomes Market Size 2027-2032 ($ millions)
Figure 74. Italy Exosomes Market Size 2027-2032 ($ millions)
Figure 75. Russia Exosomes Market Size 2027-2032 ($ millions)
Figure 76. Egypt Exosomes Market Size 2027-2032 ($ millions)
Figure 77. South Africa Exosomes Market Size 2027-2032 ($ millions)
Figure 78. Israel Exosomes Market Size 2027-2032 ($ millions)
Figure 79. Turkey Exosomes Market Size 2027-2032 ($ millions)
Figure 80. Global Exosomes Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Exosomes Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Exosomes Market Size 2027-2032 ($ millions)
Figure 1. Exosomes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exosomes Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Exosomes Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Exosomes Sales Market Share by Country/Region (2025)
Figure 8. Exosomes Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Exosomes Market Size Market Share by Type in 2025
Figure 10. Global Exosomes Market Size Market Share by Source Type in 2025
Figure 11. Global Exosomes Market Size Market Share by End User in 2025
Figure 12. Exosomes in Tumors
Figure 13. Global Exosomes Market: Tumors (2021-2026) & ($ millions)
Figure 14. Exosomes in Neurological Diseases
Figure 15. Global Exosomes Market: Neurological Diseases (2021-2026) & ($ millions)
Figure 16. Exosomes in Regenerative Medicine
Figure 17. Global Exosomes Market: Regenerative Medicine (2021-2026) & ($ millions)
Figure 18. Exosomes in Other
Figure 19. Global Exosomes Market: Other (2021-2026) & ($ millions)
Figure 20. Global Exosomes Market Size Market Share by Application in 2025
Figure 21. Global Exosomes Revenue Market Share by Player in 2025
Figure 22. Global Exosomes Market Size Market Share by Region (2021-2026)
Figure 23. Americas Exosomes Market Size 2021-2026 ($ millions)
Figure 24. APAC Exosomes Market Size 2021-2026 ($ millions)
Figure 25. Europe Exosomes Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Exosomes Market Size 2021-2026 ($ millions)
Figure 27. Americas Exosomes Value Market Share by Country in 2025
Figure 28. United States Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Exosomes Market Size Market Share by Region in 2025
Figure 33. APAC Exosomes Market Size Market Share by Type (2021-2026)
Figure 34. APAC Exosomes Market Size Market Share by Application (2021-2026)
Figure 35. China Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 39. India Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Exosomes Market Size Market Share by Country in 2025
Figure 42. Europe Exosomes Market Size Market Share by Type (2021-2026)
Figure 43. Europe Exosomes Market Size Market Share by Application (2021-2026)
Figure 44. Germany Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 45. France Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Exosomes Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Exosomes Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Exosomes Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Exosomes Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Exosomes Market Size 2027-2032 ($ millions)
Figure 58. APAC Exosomes Market Size 2027-2032 ($ millions)
Figure 59. Europe Exosomes Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Exosomes Market Size 2027-2032 ($ millions)
Figure 61. United States Exosomes Market Size 2027-2032 ($ millions)
Figure 62. Canada Exosomes Market Size 2027-2032 ($ millions)
Figure 63. Mexico Exosomes Market Size 2027-2032 ($ millions)
Figure 64. Brazil Exosomes Market Size 2027-2032 ($ millions)
Figure 65. China Exosomes Market Size 2027-2032 ($ millions)
Figure 66. Japan Exosomes Market Size 2027-2032 ($ millions)
Figure 67. Korea Exosomes Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Exosomes Market Size 2027-2032 ($ millions)
Figure 69. India Exosomes Market Size 2027-2032 ($ millions)
Figure 70. Australia Exosomes Market Size 2027-2032 ($ millions)
Figure 71. Germany Exosomes Market Size 2027-2032 ($ millions)
Figure 72. France Exosomes Market Size 2027-2032 ($ millions)
Figure 73. UK Exosomes Market Size 2027-2032 ($ millions)
Figure 74. Italy Exosomes Market Size 2027-2032 ($ millions)
Figure 75. Russia Exosomes Market Size 2027-2032 ($ millions)
Figure 76. Egypt Exosomes Market Size 2027-2032 ($ millions)
Figure 77. South Africa Exosomes Market Size 2027-2032 ($ millions)
Figure 78. Israel Exosomes Market Size 2027-2032 ($ millions)
Figure 79. Turkey Exosomes Market Size 2027-2032 ($ millions)
Figure 80. Global Exosomes Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Exosomes Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Exosomes Market Size 2027-2032 ($ millions)
